文献速递糖尿病

亚洲印度人早发糖尿病与较低的实测及遗传决定的β细胞功能相关

Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function.
PubMed 文献 · Diabetologia · 2022-03-05

研究比较亚洲印度人与白种欧洲人早发糖尿病中瘦型表型及β细胞功能,采用横断面设计。结果显示亚洲印度人正常BMI的早发糖尿病患病率为24-39%,白种欧洲人为9.3%;瘦型亚洲印度人刺激后C肽较肥胖者低492 pmol/ml。亚洲印度人遗传决定的β细胞功能低于白种欧洲人(p<0.0001)。

要点

  • 亚洲印度人早发糖尿病中正常BMI者占24-39%,白种欧洲人为9.3%。
  • 瘦型亚洲印度人刺激后C肽较肥胖者低492 pmol/ml(IQR 353-616,p<0.0001)。
  • 亚洲印度人遗传决定的β细胞功能低于白种欧洲人(p<0.0001)。

核心结论

  • 亚洲印度人早发糖尿病中瘦型BMI患病率是白种欧洲人的两倍以上,此瘦型早发糖尿病表型部分由较低的β细胞功能驱动。
  • 亚洲印度人糖尿病患者的遗传决定β细胞功能也低于白种欧洲人。

研究设计与样本

  • 横断面设计,使用两个亚洲印度人队列(ICMR-INDIAB队列和DMDSC队列)及一个白种欧洲人队列(ESDC队列),并在UK Biobank中复制遗传发现。
  • 比较了健康、超重和肥胖早发糖尿病参与者的患病率,按BMI分类。
  • 探索了临床测量的β细胞功能在亚洲印度人糖尿病发病中的作用,并检查了因β细胞功能差导致糖尿病风险的分区多基因评分(pPS)的分布。

主要发现

  • 正常BMI的早发糖尿病患病率在白种欧洲人中为9.3%,在亚洲印度人中为24-39%。
  • 在亚洲印度人早发糖尿病患者中,调整2型糖尿病家族史、性别、胰岛素敏感性和HDL-胆固醇后,瘦型者刺激后C肽较肥胖者低492 pmol/ml(IQR 353-616,p<0.0001)。
  • 本研究的亚洲印度人及UK Biobank中的南亚人风险等位基因数量高于白种欧洲人。
  • 对β细胞功能的pPS加权后,亚洲印度人遗传决定的β细胞功能低于白种欧洲人(p<0.0001)。
  • pPS与亚洲印度人的诊断年龄相关,但与白种欧洲人无关;pPS解释了临床测量β细胞功能变异的2%,以及在正常BMI、超重和肥胖BMI分类的亚洲印度人中糖尿病诊断年龄变异的1.2%、0.97%和0.36%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: South Asians in general, and Asian Indians in particular, have higher risk of type 2 diabetes compared with white Europeans, and a younger age of onset. The reasons for the younger age of onset in relation to obesity, beta cell function and insulin sensitivity are under-explored. METHODS: Two cohorts of Asian Indians, the ICMR-INDIAB cohort (Indian Council of Medical Research-India Diabetes Study) and the DMDSC cohort (Dr Mohan's Diabetes Specialties Centre), and one of white Europeans, the ESDC (East Scotland Diabetes Cohort), were used. Using a cross-sectional design, we examined the comparative prevalence of healthy, overweight and obese participants with young-onset diabetes, classified according to their BMI. We explored the role of clinically measured beta cell function in diabetes onset in Asian Indians. Finally, the comparative distribution of a partitioned polygenic score (pPS) for risk of diabetes due to poor beta cell function was examined. Replication of the genetic findings was sought using data from the UK Biobank. RESULTS: The prevalence of young-onset diabetes with normal BMI was 9.3% amongst white Europeans and 24-39% amongst Asian Indians. In Asian Indians with young-onset diabetes, after adjustment for family history of type 2 diabetes, sex, insulin sensitivity and HDL-cholesterol, stimulated C-peptide was 492 pmol/ml (IQR 353-616, p<0.0001) lower in lean compared with obese individuals. Asian Indians in our study, and South Asians from the UK Biobank, had a higher number of risk alleles than white Europeans. After weighting the pPS for beta cell function, Asian Indians have lower genetically determined beta cell function than white Europeans (p<0.0001). The pPS was associated with age of diagnosis in Asian Indians but not in white Europeans. The pPS explained 2% of the variation in clinically measured beta cell function, and 1.2%, 0.97%, and 0.36% of variance in age of diabetes amongst Asian Indians with normal BMI, or classified as overweight and obese BMI, respectively. CONCLUSIONS/INTERPRETATION: The prevalence of lean BMI in young-onset diabetes is over two times higher in Asian Indians compared with white Europeans. This phenotype of lean, young-onset diabetes appears driven in part by lower beta cell function. We demonstrate that Asian Indians with diabetes also have lower genetically determined beta cell function.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Siddiqui MK, Anjana RM, Dawed AY, et al. Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function. Diabetologia. 2022. PMID: 35247066. doi:10.1007/s00125-022-05671-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。